H-CYTE (HCYTD)
OTHER OTC:HCYTD
US Market

H-CYTE (HCYTD) Financial Statements

0 Followers

H-CYTE Financial Overview

H-CYTE's market cap is currently ―. The company's EPS TTM is $-46.58; its P/E ratio is ―; H-CYTE is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 379.56K$ 324.68K$ 460.22K$ 450.46K$ 376.17K
Gross Profit$ 293.06K$ 173.43K$ 321.43K$ 234.44K$ 177.52K
EBIT$ -3.82M$ -680.63K$ -536.10K$ -2.00M$ -1.40M
EBITDA$ -3.82M$ -678.66K$ -535.79K$ -2.00M$ -1.39M
Net Income Common Stockholders$ -3.89M$ -747.02K$ -586.61K$ -2.06M$ -1.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 95.17K$ 307.21K$ 332.31K$ 341.28K$ 1.52M
Total Assets$ 701.25K$ 321.40K$ 740.78K$ 1.98M$ 946.32K
Total Debt$ 708.59K$ 876.21K$ 989.53K$ 3.05M$ 3.71M
Net Debt$ 613.42K$ 569.00K$ 657.22K$ 2.71M$ 2.20M
Total Liabilities$ 4.83M$ 4.98M$ 4.82M$ 5.63M$ 3.40M
Stockholders Equity$ 855.84K$ -4.13M$ -4.66M$ -3.71M$ -3.28M
Cash Flow-
Free Cash Flow$ -884.26K$ -821.69K$ -1.25M$ -1.44M$ -1.31M
Operating Cash Flow$ -884.26K$ -821.70K$ -1.25M$ -1.43M$ -1.31M
Investing Cash Flow$ 0.00$ 2.00$ 0.00$ -6.31K$ -1.52K
Financing Cash Flow$ 1.13M$ 609.65K$ 38.18K$ 2.62M$ 0.00
Currency in USD

H-CYTE Earnings and Revenue History

H-CYTE Debt to Assets

H-CYTE Cash Flow

H-CYTE Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis